[1] |
Iwasenko JM, Howard J, Arbuckle S, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy[J]. J Infect Dis, 2011, 203(11):1526-1533.
URL
|
[2] |
Leruez-Ville M, Foulon I, Pass R, et al. Cytomegalovirus infection during pregnancy: state of the science[J]. Am J Obstet Gynecol, 2020, 223(3):330-349.
|
[3] |
林晓倩,王景美,刘景丽,等. 巨细胞病毒宫内感染与胎儿严重畸形的相关性研究[J]. 中华围产医学杂志,2015, 18(11):818-822.
|
[4] |
Zhang S, Hu L, Chen J, et al. Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy/neonatal outcomes in Jiangsu Province, China[J]. PLoS One, 2014, 9(9):e107645.
|
[5] |
王婷,段歌红,陈茂才,等. 人巨细胞病毒在华中地区孕妇和住院儿童群体中的流行病学调查[J]. 微生物与感染,2015, 10(5):288-293.
URL
|
[6] |
北京地区母婴巨细胞病毒感染调查协作组. 北京地区母婴巨细胞病毒感染状况调查[J].中华围产医学杂志,2012, 15(8):459-461.
|
[7] |
Society for Maternal-Fetal Medicine (SMFM). Diagnosis and antenatal management of congenital cytomegalovirus infection[J]. Am J Obstet Gynecol, 2016, 214(6):B5-B11.
|
[8] |
Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy[J]. Clin Microbiol Infect, 2011, 17(9):1285-1293.
|
[9] |
Zammarchi L, Lazzarotto T, Andreoni M, et al. Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir? [J]. Clin Microbiol Infect, 2020, S1198-743X(20)30193-2.
|
[10] |
Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status [J]. N Engl J Med, 1992, 326(10):663-667.
|
[11] |
周乙华. 妊娠期巨细胞病毒感染诊断与处理[J]. 实用妇产科杂志,2018, 34(12): 885-888.
|
[12] |
中华医学会围产医学分会,中华医学会妇产科学分会产科学组,《中华围产医学杂志》编辑委员会. 妊娠期巨细胞病毒感染筛查与处理专家共识[J]. 中华围产医学杂志,2017, 20(8): 553-556.
|
[13] |
周乙华,胡娅莉. 重视围产感染的合理诊治和预防. 中华围产医学杂志,2015, 18(11):801-804.
|
[14] |
Faure-Bardon V, Magny JF, Parodi M, et al. Sequelae of congenital cytomegalovirus following maternal primary infections are limited to those acquired in the first trimester of pregnancy[J]. Clin Infect Dis, 2019, 69(9):1526-1532.
|
[15] |
Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection[J]. N Engl J Med, 2005, 353(13):1350-1362.
|
[16] |
Nigro G. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease[J]. Expert Rev Anti Infect Ther, 2017, 15(11):977-986.
|
[17] |
Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus[J]. N Engl J Med, 2014, 370(14):1316-1326.
|
[18] |
Leruez-Ville M, Ghout I, Bussières L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase Ⅱ study[J]. Am J Obstet Gynecol, 2016, 215(4):462.e1-462.e10.
|
[19] |
De Santis M, Apicella M, De Luca C, et al. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series[J]. J Clin Virol, 2020, 127:1-7.
|
[20] |
周乙华,胡娅莉. 巨细胞病毒抗体阳性母亲的母乳喂养[J]. 中华围产医学杂志,2017, 20(8):568-570.
|
[21] |
朱晓琴,陈丽平,刘兰华,等. 不同喂养和分娩方式对婴儿巨细胞病毒感染的影响及其结局[J]. 中华围产医学杂志,2017, 20(8):571-576.
|
[22] |
徐陈瑜,陈廷美,周乙华. 母亲感染和母乳喂养[J]. 中华围产医学杂志,2019, 22(7):436-440.
|